Nanotechnology Now - Press Release: Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments

Home > Press > Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP), the developer of the NanoMask™, in the response to comments issued by the U.S. Food and Drug Administration (FDA) in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.

Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments

CARLSBAD, CA and LAS VEGAS, NV | Posted on September 19th, 2008

"We have been working diligently to help EFP prepare the response to FDA comments regarding the NanoMask pre-market notification, especially as it relates to the antimicrobial silver nanoparticle formulation which powers the NanoMask," said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management and scientific team plan to rapidly provide EFP with the necessary data to satisfy the FDA comments."

####

About Applied Nanoscience Inc.
ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products (NanoFense™) to customers worldwide and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential.

EFP is a filtration technology company that has a unique and highly efficient hydrophobic micro-particle silver nanoparticle coated medical air filter mask, the NanoMask, which is designed to reduce bioburden on contact for in diverse high challenge medical filtration venues. EFP has recently submitted a 510(k) medical device notification with the FDA for its surgical NanoMask.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP and ANI do not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.

For more information, please click here

Contacts:
Philippe Niemetz
800-477-7570 or 212-344-6464

Investor Relations
PAN Consultants Ltd.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: